Adar1 Capital Management, LLC Prothena Corp Public LTD CO Transaction History
Adar1 Capital Management, LLC
- $652 Billion
- Q2 2025
A detailed history of Adar1 Capital Management, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 3,375,009 shares of PRTA stock, worth $25.4 Million. This represents 3.14% of its overall portfolio holdings.
Number of Shares
3,375,009Holding current value
$25.4 Million% of portfolio
3.14%Shares
3 transactions
Others Institutions Holding PRTA
# of Institutions
212Shares Held
33.5MCall Options Held
848KPut Options Held
648K-
Black Rock Inc. New York, NY3.86MShares$29.1 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$16.9 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.18MShares$16.4 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.27MShares$9.61 Million1.75% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.18MShares$8.91 Million0.01% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $354M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...